Tag Archives: head and neck cancer

Combining radiation with a PI3K/MTOR inhibitor

Patients with HPV-negative head and neck cancer (HNSCC) carry a poor prognosis despite optimal treatment with chemoradiation, with a 5 year survival of less than 50%. The future for this disease must lie in further escalation of

A growing epidemic: HPV-related oropharyngeal carcinoma

The incidence of Human Papillomavirus(HPV)related oropharyngeal cancer has increased by epidemic proportions (225%) over the past 30 years. If it continues to increase at the current rate, the incidence of HPVrelated oropharyngeal cancer will be even greater